-transparent.png){kind=logo}
The effects of the anti-estrogens 4-hydroxytamoxifen (OHTam), ICI 164,384 and ICI 182,780 were tested on the MCF-7/LCC2 breast-carcinoma cell line, which grows significantly in the presence of OHTam and serves as a model for studying anti-estrogen resistance of estrogen-receptor-positive breast cancer. Cell proliferation and cathepsin-D secretion were strongly inhibited by either ICI 182,780 or ICI 164,384 alone or ICI 164,384 in combination with 17-beta-estradiol (E2) or OHTam. ICI 164,384 alone did not affect the cathepsin-D and pS2 mRNA levels, but antagonized the stimulatory effects of E2 or OHTam on these 2 mRNAs. OHTam was more effective than E2 in increasing cathepsin-D mRNA levels, supporting the idea that anti-estrogen-resistant breast cancer continues to overexpress cathepsin-D. These data show that the steroidal anti-estrogens ICI 164,384 and ICI 182,780 retain their ability to inhibit cell proliferation and the estrogen-responsiveness of cathepsin-D and pS2 genes in the OHTam-resistant MCF-7/LCC2 cell lines. These pure anti-estrogens may thus be efficient second-line treatments of some Tamoxifen-resistant tumors.
P Coopman, and
M Garcia, and
N Brünner, and
D Derocq, and
R Clarke, and
H Rochefort
March 1994,
Cancer research,
P Coopman, and
M Garcia, and
N Brünner, and
D Derocq, and
R Clarke, and
H Rochefort
April 1996,
Annals of the New York Academy of Sciences,
P Coopman, and
M Garcia, and
N Brünner, and
D Derocq, and
R Clarke, and
H Rochefort
January 1993,
Anticancer research,
P Coopman, and
M Garcia, and
N Brünner, and
D Derocq, and
R Clarke, and
H Rochefort
November 1996,
International journal of cancer,
P Coopman, and
M Garcia, and
N Brünner, and
D Derocq, and
R Clarke, and
H Rochefort
December 1998,
Oncology,
P Coopman, and
M Garcia, and
N Brünner, and
D Derocq, and
R Clarke, and
H Rochefort
January 1993,
Cancer chemotherapy and pharmacology,
P Coopman, and
M Garcia, and
N Brünner, and
D Derocq, and
R Clarke, and
H Rochefort
May 2005,
Cancer chemotherapy and pharmacology,
P Coopman, and
M Garcia, and
N Brünner, and
D Derocq, and
R Clarke, and
H Rochefort
June 1999,
Breast cancer research and treatment,
P Coopman, and
M Garcia, and
N Brünner, and
D Derocq, and
R Clarke, and
H Rochefort
October 1998,
Journal of the National Cancer Institute,
P Coopman, and
M Garcia, and
N Brünner, and
D Derocq, and
R Clarke, and
H Rochefort
November 1993,
International journal of cancer,
